- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ann Arbor Stage IIB Hodgkin Lymphoma in Korea, Republic of
Total 664 results
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IIIA Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IIB Hodgkin Lymphoma | Childhood Hodgkin LymphomaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma | Ann Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma | Ann Arbor Stage III Nodular Sclerosis Classic Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IV... and other conditionsUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Childhood Hodgkin Lymphoma | Ann Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Ann Arbor Stage III Childhood Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Hodgkin LymphomaUnited States, Canada, Australia, Switzerland
-
National Cancer Institute (NCI)Celgene CorporationActive, not recruitingAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAnn Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdult T Acute Lymphoblastic Leukemia | Childhood T Acute Lymphoblastic Leukemia | Ann Arbor Stage II Adult Lymphoblastic Lymphoma | Ann Arbor Stage II Childhood Lymphoblastic Lymphoma | Ann Arbor Stage III Adult Lymphoblastic Lymphoma | Ann Arbor Stage III Childhood Lymphoblastic Lymphoma | Ann... and other conditionsUnited States, Canada, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage I Childhood Hodgkin Lymphoma | Ann Arbor Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant B-Cell LymphomaUnited States, Canada, Australia, New Zealand, Puerto Rico, Israel
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Seoul National University HospitalCompletedNon-hodgkin Lymphoma,B CellKorea, Republic of
-
GC Cell CorporationUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
AbClonRecruitingB-cell Non Hodgkin LymphomaKorea, Republic of
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell LymphomaUnited States
-
Soonchunhyang University HospitalCompletedNon-hodgkin LymphomaKorea, Republic of
-
Seoul National University HospitalNot yet recruitingDiffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin LymphomaKorea, Republic of
-
Seoul National University HospitalGyeongsang National University Hospital; Hallym University Medical Center; Kyunghee...TerminatedCD20-positive Non-Hodgkin LymphomaKorea, Republic of
-
Asan Medical CenterSchering-PloughCompletedNon-Hodgkin's LymphomaKorea, Republic of
-
National Cancer Center, KoreaAsan Medical Center; Severance HospitalUnknownHodgkin's LymphomaKorea, Republic of
-
Keimyung University Dongsan Medical CenterOtsuka Pharmaceutical Co., Ltd.RecruitingLymphoma, Extranodal NK-T-Cell | T-cell Non-Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterJanssen Medical AffairsCompletedNon-Hodgkin Lymphoma | Peripheral T-Cell LymphomasKorea, Republic of
-
TakedaCompletedClassical Hodgkin Lymphoma | Relapsed or Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin LymphomaKorea, Republic of
-
Soonchunhyang University HospitalCompletedNon-Hodgkin's LymphomaKorea, Republic of
-
Asan Medical CenterBoryung Pharmaceutical Co., LtdCompletedNon-Hodgkin's LymphomaKorea, Republic of
-
Asan Medical CenterEli Lilly and CompanyTerminatedNon-Hodgkin's Lymphoma | Marginal Zone LymphomaKorea, Republic of
-
Dong-A University HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedB-cell LymphomasKorea, Republic of
-
Seoul National University HospitalGilead Sciences; Konkuk University HospitalUnknownNon-Hodgkin's Lymphoma, Burkitt'sKorea, Republic of
-
Samsung Medical CenterSamsung Genomic InstituteRecruitingLymphoma, Non-Hodgkin | Lymphoma, HodgkinKorea, Republic of
-
Yonsei UniversityJW PharmaceuticalCompleted
-
Samsung Medical CenterCompletedPrimary Mediastinal Large B-cell Lymphoma | Relapsed or Refractory Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Anaplastic Large Cell Lymphoma & Hodgkin LymphomaKorea, Republic of
-
Ajou University School of MedicineUnknownLymphoblastic LymphomaKorea, Republic of
-
IGM Biosciences, Inc.No longer availableRelapsed/Refractory Non-Hodgkin LymphomasAustralia, Korea, Republic of, Spain
-
Samsung Medical CenterCompletedNon-Hodgkin T-cell LymphomaKorea, Republic of
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterRecruitingPeripheral T-cell LymphomaKorea, Republic of
-
Inje UniversityUnknownNon Hodgkin's LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedRelapsed or Refractory Peripheral T-cell LymphomaKorea, Republic of
-
National Cancer Center, KoreaRecruitingRelapsed/Refractory Classical Hodgkin LymphomaKorea, Republic of
-
Samsung Medical CenterRecruitingRelapsed and/or Refractory Non-Hodgkin T-cell LymphomaKorea, Republic of
-
Samsung Medical CenterUnknownExtranodal NK-T-Cell LymphomaKorea, Republic of
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Inje University; Severance HospitalUnknown
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Childhood Hodgkin Lymphoma | Stage IV Childhood Hodgkin Lymphoma | Stage I Childhood Hodgkin Lymphoma | Stage II Childhood Hodgkin Lymphoma | Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma | Childhood Lymphocyte-Depleted Classical Hodgkin Lymphoma | Childhood Mixed Cellularity... and other conditionsUnited States, Canada, Australia, New Zealand, Puerto Rico, Switzerland, Israel
-
CelltrionCompletedFollicular LymphomaKorea, Republic of
-
Korean Breast Cancer Study GroupUnknownBreast Cancer Stage II | Breast Cancer Stage IIIKorea, Republic of
-
Samsung Medical CenterUnknownFollicular LymphomaKorea, Republic of
-
Yonsei UniversityUnknown
-
Samsung Medical CenterUnknownMantle Cell LymphomaKorea, Republic of
-
Seoul National University HospitalConsortium for Improving Survival of LymphomaCompletedMantle Cell LymphomaKorea, Republic of
-
Samsung Medical CenterCompletedMantle Cell LymphomaKorea, Republic of